Becton Dickinson Invests $56 Million Dollars in a Syringe Production Plant in Mexico

Medical technology company Becton Dickinson is investing $56 million in its Cuautitlán Izcalli plant in Mexico to establish a high-tech pre-filled glass syringe production line for vaccines.

The new Becton Dickinson plant will be ready in August 2022. Photo: JVD Biomédica

08/20/2021

Medical technology company Becton Dickinson (BD) has announced a $56 million investment in its plant located in Cuautitlán Izcalli, State of Mexico. The objective of this investment is to establish a high-tech pre-filled glass syringe production line for vaccines.

In addition, a new assembly plant for the device caps will be constructed. These projects will be situated within BD's existing facilities in the Cuamatla Industrial Park.

The investment is expected to create 200 direct jobs and 400 indirect jobs for builders, operators, and industry professionals. The new infrastructure will span 4,000 square meters across a two-story building.

Completion of the projects is anticipated by August 2022, expanding the Cuautitlán Izcalli plant's total construction area to 130,000 square meters.

Read the full article (in Spanish).

Latam

Mexico

Mexico City

Industrial

Market Analytics

Investments

ABOUT SiiLA

Founded in 2015, SiiLA is the industry leading REsource for comprehensive commercial real estate market insights, news and events across Latin America. The SiiLA suite of innovative products drive greater accuracy, efficiency, and strategic advantages for top players in the commercial real estate industry.

Top Properties in SPOT